230 related articles for article (PubMed ID: 20576537)
1. Structure-function relationship of king cobra cathelicidin.
Zhang Y; Zhao H; Yu GY; Liu XD; Shen JH; Lee WH; Zhang Y
Peptides; 2010 Aug; 31(8):1488-93. PubMed ID: 20576537
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of novel reptile cathelicidins from elapid snakes.
Zhao H; Gan TX; Liu XD; Jin Y; Lee WH; Shen JH; Zhang Y
Peptides; 2008 Oct; 29(10):1685-91. PubMed ID: 18620012
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of a snake cathelicidin-related peptide, BF-15.
Chen W; Yang B; Zhou H; Sun L; Dou J; Qian H; Huang W; Mei Y; Han J
Peptides; 2011 Dec; 32(12):2497-503. PubMed ID: 22008732
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects, cell selectivity and structure-activity relationship of a novel antimicrobial peptide polybia-MPI.
Wang KR; Zhang BZ; Zhang W; Yan JX; Li J; Wang R
Peptides; 2008 Jun; 29(6):963-8. PubMed ID: 18328599
[TBL] [Abstract][Full Text] [Related]
5. Isolation, characterization and anti-cancer activity of SK84, a novel glycine-rich antimicrobial peptide from Drosophila virilis.
Lu J; Chen ZW
Peptides; 2010 Jan; 31(1):44-50. PubMed ID: 19799950
[TBL] [Abstract][Full Text] [Related]
6. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
7. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
Lee EK; Kim YC; Nan YH; Shin SY
Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of indolicidin, a Trp-rich antibacterial peptide.
Ando S; Mitsuyasu K; Soeda Y; Hidaka M; Ito Y; Matsubara K; Shindo M; Uchida Y; Aoyagi H
J Pept Sci; 2010 Apr; 16(4):171-7. PubMed ID: 20196123
[TBL] [Abstract][Full Text] [Related]
9. The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.
Tajbakhsh M; Karimi A; Tohidpour A; Abbasi N; Fallah F; Akhavan MM
J Microbiol; 2018 Feb; 56(2):128-137. PubMed ID: 29392557
[TBL] [Abstract][Full Text] [Related]
10. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.
Pál T; Sonnevend A; Galadari S; Conlon JM
Regul Pept; 2005 Jul; 129(1-3):85-91. PubMed ID: 15927702
[TBL] [Abstract][Full Text] [Related]
11. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides.
Zhang L; Benz R; Hancock RE
Biochemistry; 1999 Jun; 38(25):8102-11. PubMed ID: 10387056
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
Lee DL; Hodges RS
Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
Rostom SA; Ashour HM; Abd El Razik HA
Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
[TBL] [Abstract][Full Text] [Related]
14. Identification of chicken cathelicidin-2 core elements involved in antibacterial and immunomodulatory activities.
van Dijk A; Molhoek EM; Veldhuizen EJ; Bokhoven JL; Wagendorp E; Bikker F; Haagsman HP
Mol Immunol; 2009 Aug; 46(13):2465-73. PubMed ID: 19524300
[TBL] [Abstract][Full Text] [Related]
15. The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.
Rajasekaran G; Kumar SD; Yang S; Shin SY
Eur J Med Chem; 2019 Nov; 182():111623. PubMed ID: 31473417
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
17. Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.
Knappe D; Piantavigna S; Hansen A; Mechler A; Binas A; Nolte O; Martin LL; Hoffmann R
J Med Chem; 2010 Jul; 53(14):5240-7. PubMed ID: 20565063
[TBL] [Abstract][Full Text] [Related]
18. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
Al-Saadi MS; Faidallah HM; Rostom SA
Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]